Dynamic Technology Lab’s Neurogene NGNE Stock Holding History

Dynamic Technology Lab’s Portfolio NGNE Stock Details NGNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-2,319	Closed	-$136K	–	1197
2018 Q3	$136K	Buy	+2,319	New	+$137K	0.02%	931

Other funds holding NGNE

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

HCM

Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Dynamic Technology Lab's NGNE Position: Q4 2018 in Review

Dynamic Technology Lab sold out of Neurogene (NGNE) in Q4 2018, closing a stake of 2,319 shares — an estimated $136K sold.

Dynamic Technology Lab first reported a position in NGNE in Q3 2018 and held it in 1 quarter. The position peaked at $136K in Q3 2018. 36 funds tracked by Wall St. Rank hold NGNE as of Q4 2018.

Dynamic Technology Lab reported no remaining Neurogene position as of Q4 2018 after selling out during the quarter.
Dynamic Technology Lab sold 2,319 Neurogene shares in Q4 2018, an estimated $136K.
Dynamic Technology Lab first reported a position in Neurogene in Q3 2018 and held it in 1 quarter.
Dynamic Technology Lab's Neurogene position peaked at $136K in Q3 2018.
36 funds tracked by Wall St. Rank held Neurogene as of Q4 2018.

Based on Dynamic Technology Lab's 13F filing for Q4 2018, filed 13 Feb 2019.